File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Designer babies

TitleDesigner babies
Authors
KeywordsDesigner babies
Embryo editing
Engineering nuclease
Mitochondria
Issue Date2016
PublisherElsevier Inc.
Citation
Obstetrics Gynaecology & Reproductive Medicine, 2016, v. 26, p. 59-60 How to Cite?
AbstractDesigner babies are either created from an embryo selected by preimplantation genetic diagnosis (PGD) or genetically modified in order to influence the traits of the resulting children. The primary aim of creating designer babies is to avoid their having heritable diseases coded by mutations in DNA. With the development on mitochondria DNA transfer and discovery of genome-editing tools, the production of precise genome-edited designer babies is no longer science fiction. However, knowledge on the risk of these editing tools is insufficient especially when modifications are heritable. Furthermore, there are ethical concerns as to whether we should apply these technologies to create designer babies. We believe that these germline genetic editing methods should still be considered as experimental procedures and research should continue to improve the method and to assess its long term safety
Persistent Identifierhttp://hdl.handle.net/10722/234869

 

DC FieldValueLanguage
dc.contributor.authorPang, TKR-
dc.contributor.authorHo, PC-
dc.date.accessioned2016-10-14T13:49:46Z-
dc.date.available2016-10-14T13:49:46Z-
dc.date.issued2016-
dc.identifier.citationObstetrics Gynaecology & Reproductive Medicine, 2016, v. 26, p. 59-60-
dc.identifier.urihttp://hdl.handle.net/10722/234869-
dc.description.abstractDesigner babies are either created from an embryo selected by preimplantation genetic diagnosis (PGD) or genetically modified in order to influence the traits of the resulting children. The primary aim of creating designer babies is to avoid their having heritable diseases coded by mutations in DNA. With the development on mitochondria DNA transfer and discovery of genome-editing tools, the production of precise genome-edited designer babies is no longer science fiction. However, knowledge on the risk of these editing tools is insufficient especially when modifications are heritable. Furthermore, there are ethical concerns as to whether we should apply these technologies to create designer babies. We believe that these germline genetic editing methods should still be considered as experimental procedures and research should continue to improve the method and to assess its long term safety-
dc.languageeng-
dc.publisherElsevier Inc. -
dc.relation.ispartofObstetrics Gynaecology & Reproductive Medicine-
dc.rightsPosting accepted manuscript (postprint): © <year>. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.subjectDesigner babies-
dc.subjectEmbryo editing-
dc.subjectEngineering nuclease-
dc.subjectMitochondria-
dc.titleDesigner babies-
dc.typeArticle-
dc.identifier.emailPang, TKR: rtkpang@hku.hk-
dc.identifier.emailHo, PC: pcho@hku.hk-
dc.identifier.authorityPang, TKR=rp01761-
dc.identifier.authorityHo, PC=rp00325-
dc.identifier.doi10.1016/j.ogrm.2015.11.011-
dc.identifier.scopuseid_2-s2.0-84961218710-
dc.identifier.hkuros268674-
dc.identifier.volume26-
dc.identifier.spage59-
dc.identifier.epage60-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats